These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
154 related items for PubMed ID: 12888182
1. S100B and response to treatment in major depression: a pilot study. Arolt V, Peters M, Erfurth A, Wiesmann M, Missler U, Rudolf S, Kirchner H, Rothermundt M. Eur Neuropsychopharmacol; 2003 Aug; 13(4):235-9. PubMed ID: 12888182 [Abstract] [Full Text] [Related]
2. The effects of gender and numbers of depressive episodes on serum S100B levels in patients with major depression. Yang K, Xie GR, Hu YQ, Mao FQ, Su LY. J Neural Transm (Vienna); 2008 Dec; 115(12):1687-94. PubMed ID: 18982242 [Abstract] [Full Text] [Related]
3. The astroglial protein S100B and visually evoked event-related potentials before and after antidepressant treatment. Hetzel G, Moeller O, Evers S, Erfurth A, Ponath G, Arolt V, Rothermundt M. Psychopharmacology (Berl); 2005 Mar; 178(2-3):161-6. PubMed ID: 15316717 [Abstract] [Full Text] [Related]
8. Predicting outcome after severe traumatic brain injury using the serum S100B biomarker: results using a single (24h) time-point. Rainey T, Lesko M, Sacho R, Lecky F, Childs C. Resuscitation; 2009 Mar; 80(3):341-5. PubMed ID: 19150161 [Abstract] [Full Text] [Related]
9. Increased S100B serum levels in schizophrenic patients with tardive dyskinesia: association with dyskinetic movements. Zhang XY, Xiu MH, Chen DC, Zhu FY, Wu GY, Haile CN, Lu L, Kosten TA, Kosten TR. J Psychiatr Res; 2010 May; 44(7):429-33. PubMed ID: 19932492 [Abstract] [Full Text] [Related]
11. Serum markers support disease-specific glial pathology in major depression. Schroeter ML, Abdul-Khaliq H, Krebs M, Diefenbacher A, Blasig IE. J Affect Disord; 2008 Dec; 111(2-3):271-80. PubMed ID: 18430474 [Abstract] [Full Text] [Related]
12. S100B serum levels and word memory processing in remitted major depression as reflected by brain potentials. Zhang Y, Rothermundt M, Peters M, Wiesmann M, Hoy L, Arolt V, Emrich HM, Dietrich DE. Neuropsychobiology; 2009 Dec; 59(3):172-7. PubMed ID: 19468240 [Abstract] [Full Text] [Related]
13. Increased serum S100B in elderly, chronic schizophrenic patients: negative correlation with deficit symptoms. Schmitt A, Bertsch T, Henning U, Tost H, Klimke A, Henn FA, Falkai P. Schizophr Res; 2005 Dec 15; 80(2-3):305-13. PubMed ID: 15964742 [Abstract] [Full Text] [Related]
14. Circulating cerebral S100B protein is associated with depressive symptoms following myocardial infarction. Tulner DM, Smith OR, de Jonge P, van Melle JP, Slomp J, Storm H, Quere M, den Boer JA, Honig A, Korf J. Neuropsychobiology; 2009 Dec 15; 59(2):87-95. PubMed ID: 19325251 [Abstract] [Full Text] [Related]
15. Dynamic change of serum protein S100b and its clinical significance in patients with traumatic brain injury. Chen DQ, Zhu LL. Chin J Traumatol; 2005 Aug 15; 8(4):245-8. PubMed ID: 16042873 [Abstract] [Full Text] [Related]
16. The roles of BDNF, S100B, and oxidative stress in interferon-induced depression and the effect of antidepressant treatment in patients with chronic viral hepatitis: a prospective study. Cicek IE, Cicek E, Kayhan F, Uguz F, Erayman I, Kurban S, Yerlikaya FH, Kaya N. J Psychosom Res; 2014 Mar 15; 76(3):227-32. PubMed ID: 24529042 [Abstract] [Full Text] [Related]
17. Elevated serum S100B protein in drug-free bipolar patients during first manic episode: a pilot study. Machado-Vieira R, Lara DR, Portela LV, Gonçalves CA, Soares JC, Kapczinski F, Souza DO. Eur Neuropsychopharmacol; 2002 Jun 15; 12(3):269-72. PubMed ID: 12007679 [Abstract] [Full Text] [Related]